Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Madison Stellfox, MD, PhD
University of Pittsburgh
Poster(s):
(2186)
Treatment-emergent resistance to ceftazidime-avibactam (CZA) is more common than ceftolozane-tazobactam (CT) among patients infected with multidrug-resistant (MDR)
Pseudomonas aeruginosa
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET